Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001214659-25-010065
Filing Date
2025-07-03
Accepted
2025-07-03 21:47:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 17037
  Complete submission text file 0001214659-25-010065.txt   18786
Mailing Address NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Subject) CIK: 0001084201 (see all company filings)

EIN.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-79318 | Film No.: 251106862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 PROVIDENCE HIGHWAY BOSTON MA 02062
Business Address 333 PROVIDENCE HIGHWAY BOSTON MA 02062 5148398866
1Globe Capital LLC (Filed by) CIK: 0001562189 (see all company filings)

EIN.: 800841812 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A